D
Dharmveer Yadav
Researcher at All India Institute of Medical Sciences
Publications - 13
Citations - 269
Dharmveer Yadav is an academic researcher from All India Institute of Medical Sciences. The author has contributed to research in topics: Population & Clinical trial. The author has an hindex of 4, co-authored 13 publications receiving 65 citations.
Papers
More filters
Journal ArticleDOI
Adverse Events Reported From COVID-19 Vaccine Trials: A Systematic Review.
Rimple Jeet Kaur,Siddhartha Dutta,Pankaj Bhardwaj,Jaykaran Charan,Sameer Dhingra,Prasenjit Mitra,Kavita Singh,Dharmveer Yadav,Praveen Sharma,Sanjeev Misra +9 more
TL;DR: In this paper, the authors conducted a systematic review of COVID-19 vaccine trials and found that most of the reactions reported were mild to moderate whereas a few with severe intensity.
Journal ArticleDOI
Trace Elements as Immunoregulators in SARS-CoV-2 and Other Viral Infections.
Karthick Dharmalingam,Amandeep Birdi,Sojit Tomo,Karli Sreenivasulu,Jaykaran Charan,Dharmveer Yadav,Purvi Purohit,Praveen Sharma +7 more
TL;DR: In this paper, the authors explored the role of trace elements in viral infections with special reference to COVID-19 and their interactions with the immune system and found that trace elements having antioxidants activity not only regulate host immune responses, but also modify the viral genome.
Journal ArticleDOI
Perspectives on the role of PTEN in diabetic nephropathy: an update
Manoj Khokhar,Dipayan Roy,Anupama Modi,Riddhi Girdhar Agarwal,Dharmveer Yadav,Purvi Purohit,Praveen Sharma +6 more
TL;DR: The present review explores these facets of PTEN in the pathogenesis of IR and DN and suggests these regulatory processes might play an important role in solving the complexities of DN pathogenesis and IR, as well as the therapeutic management of DN with the help ofPTEN K27-linked polyubiquitination.
Journal ArticleDOI
Snapshot of COVID-19 Related Clinical Trials in India.
Jaykaran Charan,Rimple Jeet Kaur,Pankaj Bhardwaj,Tanuj Kanchan,Prasenjit Mitra,Dharmveer Yadav,Praveen Sharma,Sanjeev Misra +7 more
TL;DR: The aim of the present study was to analyze various clinical trials registered in Clinical Trial Registry of India exploring the interventions for COVID 19 exploring the AYUSH interventions.
Journal ArticleDOI
Analysis of Association of Angiotensin II Type 1 Receptor Gene A1166C Gene Polymorphism with Essential Hypertension
TL;DR: Genetic variation at the AT1R gene influences the risk of hypertension stratification and might serve as a predictive marker for the susceptibility to hypertension among affected families.